What I learned this Week: January 19, 2025
Why GLP-1, Creative Destruction, and a stubborn system that resists change signal the end of business as usual
Lessons of the Week
Despite the ever-increasing data suggesting that GLP-1 alters what people choose to eat, consumer product goods companies remain focused on relabeling products to appeal to GLP-1 patients. But not reformulate products. Healthcare is frustrated that direct-to-consumer healthcare companies like Hims/Hers are taking patients. But trad…
Keep reading with a 7-day free trial
Subscribe to Creative Destruction to keep reading this post and get 7 days of free access to the full post archives.